Immunoassays Market Research Reports & Industry Analysis

An immunoassay is a diagnostic test utilizing a biochemical process that detects the presence or quantifies the concentration of a substance in solutions, such as blood, serum or urine, which frequently contain a complex mixture of substances.

An immunoassay is one of the most effectual analytical tests performed due to its specificity, sensitivity and versatility. To test the concentration of a substance within a solution, immunoassay tests use specific antibodies that will react with antigens in the solution. Monoclonal antibodies provide accurate test results and are the most common antibodies used in immunoassay testing due to their ability to bind to one site of any particular molecule. To get an accurate result, the specific antibody must have a high affinity to the antigen being tested for. The number of antigens and antibodies present in the tested solution is measured. This measurement tells how much of the analyte is located within the sample and how concentrated it is.

One of the most widely used immunoassay applications for the detection of infectious disease is the enzyme-linked immunosorbant assay (ELISA). Because of its high sensitivity, the ELISA was the first screening test widely used for HIV.

Immunoassays are significant tests that perform an array of functions in conventional medicine. While it is used primarily to test for things such as HIV in the body, the test can also be used to discover new ways to test for other diseases and conditions that don’t have a direct scientific diagnostic method.

...Show More ...Show Less


Immunoassays Industry Research & Market Reports

  • Reporter Gene Assays

    ... at a CAGR of 6.5% over the analysis period 2024-2030. Luciferase Assays, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$4.6 Billion by the end of ... Read More

  • Immunoassay Systems

    ... CAGR of 3.6% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$19.4 Billion by the end of the ... Read More

  • Hemoglobin A1C (HbA1C) Testing

    ... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach ... Read More

  • Research ELISA (Enzyme-Linked Immunosorbent Assay)

    ... Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$478.6 Million ... Read More

  • High Content Screening (HCS)

    ... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the end ... Read More

  • Veterinary Rapid Test Global Market Report 2025

    ... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More

  • Mycotoxin Testing

    ... CAGR of 5.9% over the analysis period 2024-2030. Spectroscopy- & Chromatography-Based, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.6 Billion by the end of the ... Read More

  • Multiplex Detection Immunoassays

    ... at a CAGR of 3.4% over the analysis period 2024-2030. Protein-Based Multiplex Technique, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Billion by the end ... Read More

  • Immunofluorescence Assays

    ... CAGR of 4.4% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the analysis period. ... Read More

  • 2025 Global Fully Automated Immunoassay Analyzer Market Industry (2031 Outlook)

    ... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More

  • 2025 Global Fluorescence Immunoassay Analyzers Market Industry (2031 Outlook)

    ... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More

  • In Vitro Toxicology Testing

    ... 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.2 Billion by ... Read More

  • Autoimmune Disease Diagnosis

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More

  • C-Reactive Protein Testing

    ... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More

  • In Vitro Diagnostics

    ... at a CAGR of 3.4% over the analysis period 2024-2030. IVD Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the ... Read More

  • Protein Binding Assays

    ... at a CAGR of 9.4% over the analysis period 2024-2030. Equilibrium Dialysis, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$342.2 Million by the end of ... Read More

  • Automated Immunoassay Analyzers

    ... at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the ... Read More

  • Endocrine Testing

    ... CAGR of 5.0% over the analysis period 2024-2030. Thyroid Stimulating Hormone (TSH) Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.3 Billion by the end ... Read More

  • COVID-19 Testing

    ... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More

  • Automated Liquid Handling (ALH) Technologies

    ... Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More

  • 2025 Global Female Fertility And Pregnancy Rapid Test Market Industry (2031 Outlook)

    ... market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, ... Read More

  • Lateral Flow Assays

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$12.3 Billion by the end ... Read More

  • Forensic Technologies and Services

    ... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More

  • ADME-Toxicology Testing

    ... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More

  • Cancer / Tumor Profiling

    ... 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Immunoassays, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$6.7 Billion by the end ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings